Totally agree Old Eng, I find ResMed frequently gets sold down on results only to recover in US led trading in the following week or 2.
Analysts seemed to like the results in general.
I suspect arb traders are not as active when results are freshly released and Aus markets are hence susceptible to a sell down, particularly when only a small divie is visible to a dividend loving local market.
Ann: FORM 10Q for Qtr ended December, 2022, page-4
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$36.84 |
Change
0.240(0.66%) |
Mkt cap ! $22.61B | |||
| Open | High | Low | Value | Volume |
| $36.65 | $37.05 | $36.65 | $23.57M | 639.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2698 | $36.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $36.89 | 5764 | 2 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |